Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2017-11-24 15:58:59

Nse

138.75

6.75(5.11%)
Change%
52 Week Range
123.40
22.00
228.95
3.00
Open132.90
Day's Range118.80 - 145.20
Value Traded (in ₹ Cr.) 134.28

Bse

138.70

6.65(5.04%)
Change %
52 Week Range
123.40
22.00
230.90
3.00
Open132.90
Day's Range118.85 - 145.26
Value Traded (in ₹ Cr.) 9.14

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 177,927,016.00 34.31%
Mutual Funds/UTI 44,265,040.00 8.54%
FII 175,006,045.00 33.75%
Employee 0.00 0.00%
Public 75,748,440.00 14.61%
Government 0.00 0.00%
Others 42,952,276.00 8.28%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 13.29
Basic EPS (Rs.) -1.59
Cash EPS -1.04
BVPerShare Excl 77.91
Operating Revenue 13.21
PBDITPerShare 0.63
Dividend 0.00
NPPerShare -1.59
Current Ratio 1.85
Quick Ratio 1.84
PriceToBV 2.25
Earnings -0.01
PBDIT Margin 4.80
PBT Margin -12.01
NP Margin -12.01
Return On Assets -1.49
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 758.83
Total Expenses 817.00
EBITDA 29.39
PBT -73.51
PAT -73.51
Net Income -73.51
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 376.34
Total Expenses 367.99
EBITDA -5.60
PBT -30.78
PAT -30.78
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1145.2 1139.55 0.5
1023.81157

Dr. Lal Pathlabs Ltd.

889.9 889.7 0.02
859.95905

Healthcare Global Enterprises Ltd.

296.5 298.4 -0.64
281303

Indraprastha Medical Corporation Ltd.

50.75 51.1 -0.68
50.2551.5

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

33.2 34 -2.35
31.435.95

Marico Kaya Enterprises Ltd.

1547.05 1582.55 -2.24
1535.051589
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1141.5 1135.15 0.56
1023.91152.45

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

12.1 12.7 -4.72
12.112.1

Dhanvantri Jeevan Rekha Ltd.

34 35.05 -3
31.3536.2

Dolphin Medical Services Ltd.

1.03 1.03 0
0.921.05
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -693.61
Cash from investing activities 379.12
Cash from financing activities 317.58
Net change in cash 3.09

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Aditya Birla Sun Life Balanced 95 Fund 0.44%
ICICI Prudential MidCap Fund 3.52%
Reliance Arbitrage Advantage Fund 0.51%
ICICI Prudential Equity - Arbitrage Fund 0.36%
Kotak Equity Arbitrage Fund - Regular Plan 0.30%
Kotak Equity Savings Fund - Regular Plan 3.02%

Excel Industries Q2 net profit jumps 60.26% at Rs 11.01 cr

The company reported standalone net profit of Rs 11.01 crore for the quarter ended September 30, 2017 as compared to Rs 6.87 crore in the same period last year, registering a year-on-year growth of 60.26 per cent. Net revenue of the company rose moderately by 6.02 per cent at Rs 130.02 crore in July-September quarter of this fiscal as against Rs 122.64 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 0.72 per cent to Rs 108.27 crore from Rs 109.05 crore in year ago period. Other Income dipped by 71.76 per cent at Rs 0.24 crore versus (Sep'16 Rs 0.85 crore). Operating Profit surged by 45.68 per cent to Rs 21.75 crore as against Rs 14.93 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 37.36 per cent in September quarter. Interest declined by 47.90 per cent y-o-y to Rs 1.61 crore, while Taxation increased by 156.31 per cent at Rs 5.69 crore (Sep'16 Rs 2.22 crore).

24-11-2017 16:50

Skyline Millars posts Q2 net loss of Rs 0.16 cr

The company reported standalone net loss during the quarter stood at Rs 0.16 crore compared to net profit of Rs 0.53 crore in the previous year quarter. Net revenue of the company rose two fold by 245.45 per cent at Rs 1.14 crore in July-September quarter of this fiscal as against Rs 0.33 crore in the corresponding period last year. During July-September quarter, operating expenses increased by 7.37 per cent to Rs 1.02 crore from Rs 0.95 crore in year ago period. Other Income dipped by 99.43 per cent at Rs 0.01 crore versus (Sep'16 Rs 1.74 crore). Operating Profit surged by 119.35 per cent to Rs 0.12 crore as against Rs -0.62 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 105.56 per cent in September quarter.

24-11-2017 16:40

Kingfa Science & Technology Q2 net profit up 21.77%

The company reported standalone net profit of Rs 5.09 crore for the quarter ended September 30, 2017 as compared to Rs 4.18 crore in the same period last year, registering a year-on-year growth of 21.77 per cent. Net revenue of the company rose substantially by 24.78 per cent at Rs 139.87 crore in July-September quarter of this fiscal as against Rs 112.09 crore in the corresponding period last year. During July-September quarter, operating expenses increased by 23.44 per cent to Rs 130.01 crore from Rs 105.32 crore in year ago period. Other Income grew by 1058.33 per cent at Rs 1.15 crore versus (Sep'16 Rs -0.12 crore). Operating Profit surged by 45.86 per cent to Rs 9.86 crore as against Rs 6.76 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 16.92 per cent in September quarter. Interest grew by 257.75 per cent y-o-y to Rs 1.12 crore, while Taxation increased by 68.61 per cent at Rs 3.76 crore (Sep'16 Rs 2.23 crore).

24-11-2017 16:30

Valiant wins orders worth Rs 5 cr for metro projects

Valiant Communications on Friday said it has received the product approvals and letter of intents for supply of its communication solutions for Kolkata Metro Rail Corporation and Dedicated Freight Corridor projects for western Region. “The gross value of the projects exceeds Rs 5 crore,” Valiant Communications said in a filing to the Bombay Stock Exchange. Commenting on the development, Inder Mohan Sood, Managing Director said: “These are significant developments, as it also opens up the railway sector for the company to participate in the upgradation of Indian Railways.” Meanwhile, shares of company closed trade at Rs 84.00 apiece, up 6.94 per cent, on the BSE today.

24-11-2017 16:16

Alexander Stamps Q2 net profit up 6.25% at Rs 0.17 cr

The company reported standalone net profit of Rs 0.17 crore for the quarter ended September 30, 2017 as compared to Rs 0.16 crore in the same period last year, registering a year-on-year growth of 6.25 per cent. Net revenue of the company declined substantially by 57.74 per cent at Rs 1.31 crore in July-September quarter of this fiscal as against Rs 3.10 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 62.76 per cent to Rs 1.08 crore from Rs 2.90 crore in year ago period. Operating Profit surged by 15.00 per cent to Rs 0.23 crore as against Rs 0.20 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 169.71 per cent in September quarter. Taxation increased by 40.00 per cent at Rs 0.07 crore (Sep'16 Rs 0.05 crore).

24-11-2017 15:10

Fortis Healthcare board clears RHT Health Trust portfolio acquisition

Fortis Healthcare Ltd’s board has approved the proposed acquisition of entire portfolio of Singapore-listed RHT Health Trust (RHT) for an enterprise value of around Rs4,650 crore, the company said. The step is part of a restructuring initiative aimed at consolidating the entire Indian asset portfolio comprising various clinical establishments and two operating hospitals of RHT Health Trust into Fortis. Fortis and RHT have inked a pact proposing the acquisition of all the securities of RHT’s entities in India holding, clinical entities and businesses via purchase of securities for an enterprise value of around Rs4,650 crore, Fortis said in a statement. This includes Rs1,152 crore of debt of RHT as on date, it added. “This restructuring is a significant initiative and will integrate RHT’s entire India-based asset portfolio into Fortis while also improving the overall financial health of the business,” Fortis Healthcare CEO Bhavdeep Singh said. The proposed purchase of securities will be conducted on an arm’s length basis, he added. “The proposed transaction would be funded by Fortis with a combination of equity, quasi-equity and/or debt. Fortis has an enabling resolution in place to raise capital for up to Rs5,000 crore,” Singh said. The proposed transaction will be subject to the satisfaction of conditions precedent, including regulatory and shareholder approvals by Fortis, approvals by RHT unit holders and other approvals as may be required, he added. Fortis has an indirect interest of 29.76% in RHT. The term sheet signed by both Fortis and the trustee- manager of RHT is intended to set out the basis for further discussion in respect of the proposed transaction. Both Fortis and RHT have entered into an exclusivity period for 60 days commencing from the date of the term sheet with a view to executing definitive agreements for the proposed transaction. Fortis has also entered into hospital and medical services agreements with entities held by RHT under which it pays service fees to such entities for services rendered. For 2017-18, the net cumulative service fees to be paid by Fortis to RHT is estimated to be around Rs270 crore. “Upon completion of the securities acquisition, the service fees that Fortis was paying will be completely eliminated, thereby improving significantly its operating profitability,” Fortis said. Meanwhile, shares of the company were trading at Rs 142.90 apiece, up 9.54 per cent from the previous close at 12:57 hours on BSE.

15-Nov-2017 12:51 PM

Fortis Healthcare - Outcome of Board Meeting

Fortis Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on November 14, 2017.This is to inform you that the Board of Directors of the Company at its meeting held today, inter-alia, considered and approved execution by the Company of a term sheet (?Term Sheet?) containing an exclusivity arrangement, in relation to the proposed acquisition by the Company and/or its subsidiaries of the equity and financial securities, in the relevant Indian entities under RHT Health Trust (RHT) in, International Hospital Limited and Fortis Health Management Limited (and consequentially Escorts Heart and Super Specialty Hospital Limited, Hospitalia Eastern Private Limited and Fortis Hospotel Limited) for a combined enterprise value of approx. Rs. 4650 Crores (including RHT Debt of approx. Rs. 1152 crore) from the wholly-owned subsidiaries of RHT (?Proposed Transaction?). The Proposed Transaction is subject to the satisfaction of conditions precedent including statutory approvals, shareholders, unitholders, lenders, noteholders and other approvals as may be required. The Term Sheet executed by both the Company and Trustee Manager of RHT, is intended to set out the basis for further discussion in respect of the Proposed Transaction, and is not intended to be legally binding between the parties, except for certain provisions including those relating to the consideration, confidentiality, exclusivity and governing law. Both the Company and RHT have entered into an exclusivity period for 60 days, commencing from the date of the term sheet with a view to executing definitive agreements for the Proposed Transaction. It is hereby further informed that the Un-Audited Financial Results for the quarter and half year ended on September 30, 2017 which was planned to be tabled before the Board today, could not be tabled pending finalization, which was attributed due to engagement of the team in firming aforesaid transaction. The stock exchanges shall be intimated of a fresh date of Board Meeting in due course. Further, in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (?SEBI Regulations?), it is also informed that Ms. Shradha Suri Marwah (Non-Executive Independent Director) (DIN-00176902), has tendered her resignation from Directorship of the Company with immediate effective, due to personal reasons, primarily attributed to extensive travel and imminent occupation in other companies.The detailed disclosure as required under Regulation 30 of SEBI Regulations for the Proposed Transaction is attached herewith.Further, please find enclosed the press release being issued in this regard. This is for your information and records please.

14-Nov-2017 11:57 PM

Fortis Healthcare - Updates

Fortis Healthcare Limited has informed the Exchange regarding ''Dear Sir(s),Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, November 14, 2017 to, inter-alia, consider and approve the Un-Audited Financial Results for the quarter and Half Year ended September 30, 2017.Further, the trading window of the Company for dealing in securities of the Company will remain closed from November 8, 2017 to November 16, 2017 (both days inclusive).This is for your information and record please.''.

07-Nov-2017 05:27 PM

Fortis Healthcare - Certificate Under Regulation 40(10) Of SEBI (LODR)Regulations, 2015 For The Half Year Ended September 30,

Dear Sir,

Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a Certificate received from M/s. Mukesh Agarwal & Co., Company Secretaries, for the half-year ended on September 30, 2017.

Kindly acknowledge receipt of the same.

11-Oct-2017 11:42 AM

Fortis Healthcare - Statement On Investor Complaints Under Regulation 13(3) For The Quarter Ended September 30, 2017.

Please find enclosed the Statement giving the number of investor complaints pending at the beginning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved at the end of the quarter ended September 30, 2017, as received from the Registrar and Transfer Agent, pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Further, it is also confirmed that the said statement includes the complaints directly received by the Company and that no complaint has been received on SCORES Portal during the quarter ended September 30, 2017.

You are requested to take the same on your record.

11-Oct-2017 11:35 AM

Fortis Healthcare - Certificate Under Regulation 40(10) Of SEBI (LODR)Regulations, 2015 For The Half Year Ended September 30,

Dear Sir,

Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a Certificate received from M/s. Mukesh Agarwal & Co., Company Secretaries, for the half-year ended on September 30, 2017.

Kindly acknowledge receipt of the same.

11-Oct-2017 11:42 AM

Fortis Healthcare - Statement On Investor Complaints Under Regulation 13(3) For The Quarter Ended September 30, 2017.

Please find enclosed the Statement giving the number of investor complaints pending at the beginning of the quarter, those received during the quarter, disposed of during the quarter and those remaining unresolved at the end of the quarter ended September 30, 2017, as received from the Registrar and Transfer Agent, pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Further, it is also confirmed that the said statement includes the complaints directly received by the Company and that no complaint has been received on SCORES Portal during the quarter ended September 30, 2017.

You are requested to take the same on your record.

11-Oct-2017 11:35 AM

Fortis Healthcare - Shareholding for the Period Ended September 30, 2017

Fortis Healthcare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017.

09-Oct-2017 04:17 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.